Answers are grounded in this paper and cite their sources.
Replacing the N atom with an As or P atom in antineoplastically active phospholipids 1 and 2 (Z N) leads to homologous compounds (Z As, P) that are equally effective against tumors and have fewer side effects than the N-containing phospholipids. This marks definite progress in cancer treatment with chemotherapeutically active phospholipids.
No takes yet. Share an insight, caveat, or question.
Stekar et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: